Website https://pepgel.com/

PepGel is a biotechnology company focused on advancing life science research and regenerative medicine through next-generation synthetic peptide hydrogel technologies. Originating from academic innovation, PepGel develops biomimetic materials that replicate the natural cellular microenvironment, enabling more physiologically relevant and reproducible research outcomes.

At the core of the portfolio is the proprietary PGmatrix™ platform, a fully synthetic, animal-free hydrogel system designed to mimic the human extracellular matrix (ECM). This enables cells to grow, organize, and function in true 3D structures, closely reflecting in vivo biology, supporting applications such as organoid development, stem cell expansion, drug discovery, and tissue engineering.

PepGel’s solutions are engineered for flexibility and scalability, with tunable mechanical and biochemical properties that allow seamless integration into workflows ranging from basic research to advanced applications such as bioprinting and cell-based therapies.

Through close collaboration with biotech, pharmaceutical, and academic partners, PepGel delivers not only innovative materials but also customized solutions that accelerate translational research and bring laboratory discoveries closer to clinical application.